104 related articles for article (PubMed ID: 12793407)
1. My total prostate-specific antigen (PSA) level is 0.2 nanograms per milliliter, which I'm told is normal. But my free-to-total PSA ratio is 8 percent, which I've read indicates a high risk of prostate cancer. What do these seemingly contradictory PSA results mean?
Crawford ED
Health News; 2003 Jun; 9(6):12. PubMed ID: 12793407
[No Abstract] [Full Text] [Related]
2. On call. I've had my PSA tested every year since 1992 and I'm happy to say it's always been normal. But now my doctor doesn't want to do the test anymore because I'm 78 years old. Should I go to another doctor for my test?
Simon HB
Harv Mens Health Watch; 2000 Dec; 5(5):8. PubMed ID: 11114879
[No Abstract] [Full Text] [Related]
3. On call. I am 58-year-old diabetic. I've had my PSA checked every year since I turned 50, but I'm now on kidney dialysis. Will dialysis change my PSA results?
Simon HB
Harv Mens Health Watch; 2001 Jun; 5(11):8. PubMed ID: 11439279
[No Abstract] [Full Text] [Related]
4. On call. I developed severe ulcerative colitis in my late teens, and I had my entire colon and rectum removed at age 24. It was certainly worthwhile, since I adjusted easily and I've been healthy ever since. But now I'm 52, and I'm starting to think about prostate cancer. My doctor obviously can't do a rectal exam, and he doesn't want to do a PSA test because he says he won't be able to send me for a prostate biopsy if the test is high. Do I have any options?
Simon HB
Harv Mens Health Watch; 2004 Jul; 8(12):8. PubMed ID: 15273066
[No Abstract] [Full Text] [Related]
5. Prostate specific antigen reference ranges in Saudi men.
Kamal BA; Ali GA; Taha SA
Saudi Med J; 2003 Jun; 24(6):665-8. PubMed ID: 12847600
[TBL] [Abstract][Full Text] [Related]
6. The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.
Roddam AW; Hamdy FC; Allen NE; Price CP;
BJU Int; 2007 Sep; 100(3):514-7. PubMed ID: 17542987
[TBL] [Abstract][Full Text] [Related]
7. Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).
Aus G; Becker C; Lilja H; Khatami A; Pihl CG; Hugosson J
Scand J Urol Nephrol; 2003; 37(6):466-70. PubMed ID: 14675918
[TBL] [Abstract][Full Text] [Related]
8. On call. My prostate is not enlarged and I have no urinary tract symptoms, but I've had three prostate biopsies over the past four years because my PSA has gone from 3.2 to 4.8. The first two biopsies were normal, but the new one found "PIN" but no cancer. Please explain "PIN" and tell me what it means for me. I'm 59 years old, and except for my prostate, I don't have a worry in the world.
Simon HB
Harv Mens Health Watch; 2010 Dec; 15(5):8. PubMed ID: 21207841
[No Abstract] [Full Text] [Related]
9. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
Nakano Y; Okamura K; Takamura S; Okamoto N; Narishima M; Yoshino Y; Hattori R; Ono Y; Ohshima S; Nagasaka T
Int J Urol; 2005 Aug; 12(8):721-7. PubMed ID: 16174045
[TBL] [Abstract][Full Text] [Related]
10. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
Walz J; Haese A; Scattoni V; Steuber T; Chun FK; Briganti A; Montorsi F; Graefen M; Huland H; Karakiewicz PI
Cancer; 2008 Nov; 113(10):2695-703. PubMed ID: 18853417
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.
Khan MA; Sokoll LJ; Chan DW; Mangold LA; Mohr P; Mikolajczyk SD; Linton HJ; Evans CL; Rittenhouse HG; Partin AW
Urology; 2004 Dec; 64(6):1160-4. PubMed ID: 15596190
[TBL] [Abstract][Full Text] [Related]
12. Determination of the relative probability for prostate cancer to avoid unnecessary biopsy.
Okamura K; Takaba H; Kamihira O; Kinukawa T; Ono Y; Ohshima S; Nagasaka T
Int J Urol; 2005 Apr; 12(4):346-52. PubMed ID: 15948720
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
Etzioni R; Falcon S; Gann PH; Kooperberg CL; Penson DF; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1640-5. PubMed ID: 15466981
[TBL] [Abstract][Full Text] [Related]
15. Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002.
Saraiya M; Kottiri BJ; Leadbetter S; Blackman D; Thompson T; McKenna MT; Stallings FL
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2178-82. PubMed ID: 16172229
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
Rydén L; Egevad L; Ekman P; Hellström M
Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221
[TBL] [Abstract][Full Text] [Related]
17. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
Irani J; Salomon L; Soulié M; Zlotta A; de la Taille A; Doré B; Millet C
Urology; 2005 Mar; 65(3):533-7. PubMed ID: 15780371
[TBL] [Abstract][Full Text] [Related]
18. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
[TBL] [Abstract][Full Text] [Related]
19. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
Roobol MJ; Kranse R; de Koning HJ; Schröder FH
Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
